You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • FRI0445 Faecal calprotectin, but not anti-saccharomyces cerevisiae antibodies, is linked to worse disease status in axial spondyloarthritis patients without inflammatory bowel disease: results from the spartakus cohort

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - clinical aspects (other than treatment)
FRI0445 Faecal calprotectin, but not anti-saccharomyces cerevisiae antibodies, is linked to worse disease status in axial spondyloarthritis patients without inflammatory bowel disease: results from the spartakus cohort
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017801
Jul 20171404
Aug 20171001
Sep 20172800
Oct 20172203
Nov 20172803
Dec 20172801
Jan 20184404
Feb 20182800
Mar 20183200
Apr 20181800
May 20182000
Jun 20181200
Jul 2018600
Aug 20182000
Sep 20181000
Oct 2018600
Nov 20181801
Dec 20181002
Jan 2019600
Feb 2019801
Mar 20191405
Apr 2019203
May 2019404
Jun 2019202
Jul 2019903
Aug 20191201
Sep 2019301
Oct 2019402
Nov 20191602
Dec 2019202
Jan 2020801
Feb 20201001
Mar 2020801
Apr 2020404
May 2020402
Jun 2020601
Jul 2020800
Aug 2020604
Sep 20201201
Oct 2020402
Nov 2020202
Dec 2020802
Jan 2021601
Feb 2021702
Mar 2021201
Apr 2021504
May 2021202
Jul 2021003
Aug 2021001
Sep 2021001
Oct 20214020
Nov 20214011
Dec 2021601
Feb 2022501
Mar 2022502
Apr 2022200
May 20221708
Jun 20221202
Jul 2022800
Aug 20221206
Sep 2022207
Oct 2022803
Nov 2022206
Dec 2022600
Jan 2023403
Feb 2023800
Mar 2023800
Apr 2023001
May 2023204
Jun 2023303
Jul 2023603
Aug 2023402
Sep 2023202
Oct 2023200
Nov 2023601
Dec 2023800
Jan 2024600
Feb 2024601
Mar 202412022
Total7160191